Neurosciences

Gotistobart Improves Survival in Squamous NSCLC After Chemotherapy | Nature Medicine

by

Gotistobart: A Potential Turning Point for Advanced Squamous Lung Cancer? For patients battling metastatic squamous non-small cell lung cancer (sqNSCLC) who have exhausted other treatment options, a new horizon may be emerging. Early results from the PRESERVE-003 trial, published in Nature Medicine, suggest that gotistobart, a novel anti-CTLA-4 antibody, could significantly improve survival rates compared … Read more

Therapeutic Telemedicine in Wartime: Local Control, Remote Expertise

by

The Future of Wartime Healthcare: Teletherapy Corridors and Remote Expertise The convergence of conflict and medical innovation is reshaping healthcare delivery in war zones. A novel model, dubbed ‘Teletherapy Corridors,’ is gaining traction, leveraging remote expertise to provide critical care where it’s needed most. This approach, detailed in a recent Nature Medicine publication (doi:10.1038/s41591-026-04298-6), focuses … Read more

Cancer Research: Key Affiliations & Authors

by

The Future of Cancer Immunotherapy: Beyond Checkpoints The landscape of cancer treatment is rapidly evolving, with immunotherapy taking center stage. While checkpoint inhibitors have revolutionized care for many, a significant portion of patients don’t respond. Researchers are now focusing on expanding the reach of immunotherapy, particularly for cancers with unique challenges like HLA class I … Read more

Rezatapopt Restores p53 Function & Shows Promise in Phase 1 Trial | Nature Medicine

by

Rezatapopt: A New Hope for Cancer Patients with TP53 Mutations For decades, the TP53 gene, often called the “guardian of the genome,” has been a central focus in cancer research. Mutations in this gene are found in over 50% of all human cancers. Now, a new therapeutic approach centered around the small molecule rezatapopt is … Read more

CAR-T Cell Therapy for Multiple Myeloma: Early Clinical Trial Results & Insights

by

The Future of Cancer Immunotherapy: In Vivo CAR-T Cell Therapy Gains Momentum The landscape of cancer treatment is undergoing a dramatic shift, with immunotherapy rapidly emerging as a cornerstone of care. Recent breakthroughs, particularly in CAR-T cell therapy, are offering recent hope to patients battling previously intractable cancers. Now, a potentially game-changing approach – in … Read more

Rare Pediatric Gene Therapy: Faster Approvals Blueprint

by

The Future of Hope: Accelerating Gene Therapy for Children Rare pediatric diseases, once considered medical mysteries, are increasingly becoming targets for groundbreaking cell and gene therapies. Recent advancements are dramatically shortening the time it takes to develop and deliver these potentially life-saving treatments, offering a beacon of hope for families facing previously untreatable conditions. From … Read more

POLAR Trial: Genomic and Immunologic Biomarkers in Metastatic Pancreatic Cancer

by

Precision Medicine Gains Momentum in Pancreatic and Biliary Tract Cancers: A New Era of Targeted Therapies The landscape of treatment for pancreatic and biliary tract cancers is undergoing a significant shift, moving away from broad-spectrum approaches towards highly personalized strategies. Recent clinical trials, like the POLAR and related studies, are demonstrating the potential of combining … Read more

AI Prioritization of Chest X-rays: No Impact on Lung Cancer Diagnosis Speed – Large UK Study

by

AI’s Promise for Lung Cancer Detection: A Reality Check The push to leverage artificial intelligence in healthcare continues, with significant investment focused on improving early disease detection. However, a large-scale UK study, published in Nature Medicine, has delivered a sobering assessment of AI’s current capabilities in accelerating lung cancer diagnosis. The LungIMPACT trial, involving over … Read more

PANGEA-SMM: A Novel Model for Predicting Progression in Smoldering Multiple Myeloma

by

Predicting the Unpredictable: New Tool Offers Hope in Smoldering Multiple Myeloma Monitoring Dana-Farber Cancer Institute researchers have unveiled PANGEA-SMM, a new online tool designed to more accurately predict when smoldering multiple myeloma (SMM) will progress to active cancer. This development marks a significant step forward in personalized cancer care, offering the potential to refine treatment … Read more

UK Lung Screening Program: Initial & Whole-Program Results to March 2025

by

Lung Cancer Screening Program Expands, Showing Promising Early Results The UK’s national Lung Cancer Screening Programme is rapidly expanding, with significant progress made in identifying lung cancer at earlier, more treatable stages. Data released to March 2025 reveals a substantial increase in both the number of individuals screened and the number of lung cancers diagnosed … Read more

© 2026 Newsy Today. All rights reserved.


For contact, advertising, copyright, issues email: [email protected]

For contact, advertising, copyright, issues email: [email protected]